NOT FOR REPRINT
Page Printed from: benefitspro.com/author/profile/scott-wooldridge/?page=53
Sign In To follow
Nearly half of American families have a nonelderly adult member with a pre-existing health condition.
Cost may be a major issue limiting adoption of gene therapy, but it's not the only one.
Tens of billions could be saved on drug prices under ERP, but the threat of impeachment has pushed legislating to the side.
If you're shopping for health insurance in one of these 10 states, you might find your options somewhat limited.
Despite the overall trend, there can be wide variations of usage, cost and concentration between—and even within—metro areas.
A UnitedHealth Group study suggests administering some specialty drugs outside of the hospital setting could save billions.
Small business owners are looking for ways to cut costs and interested in policy changes that would make health care more affordable.
Data on integration does not show improved care coordination—instead it suggests delivery of more services.
Consumers list personal recommendations as the most important factor in choosing a physician, followed by online reviews.
Reducing the use of high-cost, low-value drugs could lead to $63 million in annual savings.